Frontiers retracts 2018 hesperetin bone resorption study
Frontiers in Pharmacology has formally retracted a 2018 research article that claimed hesperetin prevents bone resorption by inhibiting RANKL-induced osteoclastogenesis ...
Frontiers in Pharmacology has formally retracted a 2018 research article that claimed hesperetin prevents bone resorption by inhibiting RANKL-induced osteoclastogenesis ...
Researchers have identified that the gut bacterium Fusobacterium nucleatum triggers oxaliplatin resistance in colorectal cancer cells by activating the TLR4/AP-1 ...
A comprehensive scientific review outlines how advanced biomaterial platforms target key Schwann cell signaling networks to guide cellular reprogramming and ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.